Archives

Archive for April, 2015

now, back to basics!…

( OPINION )

WHO calls for increased transparency in medical research Note for the media 14 April 2015 14 APRIL 2015 | GENEVA | WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result. The move aims to ensure that decisions related to the safety and efficacy […]

one of the many ways…

( OPINION )

Is science broken? the psychologist British Psychological Society 17th March 2015 [see also Is Science Broken? Let’s Ask Karl Popper] A lively debate was held at London’s Senate House yesterday with panellists from neuroscience and psychology discussing the question: is science broken? If so, how can we fix it? The discussion covered the replication crisis […]

GSK – churning presidents…

( OPINION )

I find this next chapter of GSK USA surrealistic. In January 2011, I read Deirdre Connelly’s speech with amazement. She was the new president of GSK USA, and she was going to shut down the program where Drug Rep’s bonuses were based on the number of prescriptions their territory’s doctors wrote [“so what went wrong?”…]… […]

under fire III…

( OPINION )

Under fire, Schulz stepping down The head of the U’s psychiatry department is leaving his role amid a swarm of criticisms. The Minnesota Daily By Christopher Aadland April 13, 2015 With the controversies around the department, especially the two recent investigations, I felt it was most constructive for me to step down as the chair […]

under fire II…

( OPINION )

I guess I ought to start this post by saying what it’s all about, because I doubt I’ll get to the end even in this second post. It’s based on some observations. First, although the direct information on Dan Markingson’s clinical state during his time in the CAFE Trial is spotty, I haven’t read anything […]

under fire I…

( OPINION )

"The development of psychopharmacologic agents over the past 6 decades has been characterized by a paradoxical relationship between medication discovery and clinical trial methodology. The methodology during the most productive decade, 1949–1958, was primitive. Since then, there have been tremendous advances in clinical trial design, assessment, and statistical analyses. Yet, despite numerous innovations in methodology, […]

still not…

( OPINION )

A call from the former Governor for University of Minnesota’s President, Eric Kaler, and involved members of the Board of Regents to step down or be removed in the wake of the recent reports on the handling of the Dan Markingson case: Markingson case: University of Minnesota can’t regain trust under current leadership Years of […]

Schulz out in Minnesota…

( OPINION )

April 8, 2015: Implementation team formed to advance University of Minnesota human subjects research protection program [UMn Announcement] April 9, 2015: The Fix is In by Leigh Turner [Commentary on the make-up of the Implementation Team] April 9, 2015: Schulz stepping down as head of psychiatry [Comments from the Dean of the Medical School on […]

without firm action…

( OPINION )

"There were approximately 600 clinical trials mentioned in the documents we gathered; owing to redactions, most of these trials could not be identified. However, in some cases, key information was not redacted from the documents, allowing us to identify 101 trials in which at least one clinical trial site received an OAI grade on an […]

the other side of the story…

( OPINION )